7-27245957-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001989.5(EVX1):c.756C>A(p.Asp252Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000222 in 1,609,240 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00038 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00021 ( 0 hom. )
Consequence
EVX1
NM_001989.5 missense
NM_001989.5 missense
Scores
3
13
3
Clinical Significance
Conservation
PhyloP100: 1.90
Genes affected
EVX1 (HGNC:3506): (even-skipped homeobox 1) This gene encodes a member of the even-skipped homeobox family characterized by the presence of a homeodomain closely related to the Drosophila even-skipped (eve) segmentation gene of the pair-rule class. The encoded protein may play an important role as a transcriptional repressor during embryogenesis. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.05486062).
BS2
High AC in GnomAd4 at 58 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EVX1 | NM_001989.5 | c.756C>A | p.Asp252Glu | missense_variant | 3/3 | ENST00000496902.7 | |
EVX1-AS | NR_120507.1 | n.269+1004G>T | intron_variant, non_coding_transcript_variant | ||||
EVX1 | NM_001304519.2 | c.210C>A | p.Asp70Glu | missense_variant | 3/3 | ||
EVX1 | NM_001304520.2 | c.210C>A | p.Asp70Glu | missense_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EVX1 | ENST00000496902.7 | c.756C>A | p.Asp252Glu | missense_variant | 3/3 | 1 | NM_001989.5 | P1 | |
EVX1 | ENST00000222761.7 | c.*95C>A | 3_prime_UTR_variant | 3/3 | 1 | ||||
EVX1-AS | ENST00000517726.1 | n.269+1004G>T | intron_variant, non_coding_transcript_variant | 3 | |||||
EVX1 | ENST00000580535.1 | c.*95C>A | 3_prime_UTR_variant | 4/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 58AN: 152206Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
58
AN:
152206
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000252 AC: 61AN: 242268Hom.: 0 AF XY: 0.000279 AC XY: 37AN XY: 132586
GnomAD3 exomes
AF:
AC:
61
AN:
242268
Hom.:
AF XY:
AC XY:
37
AN XY:
132586
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000205 AC: 299AN: 1456916Hom.: 0 Cov.: 31 AF XY: 0.000232 AC XY: 168AN XY: 725068
GnomAD4 exome
AF:
AC:
299
AN:
1456916
Hom.:
Cov.:
31
AF XY:
AC XY:
168
AN XY:
725068
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000381 AC: 58AN: 152324Hom.: 0 Cov.: 33 AF XY: 0.000389 AC XY: 29AN XY: 74476
GnomAD4 genome
AF:
AC:
58
AN:
152324
Hom.:
Cov.:
33
AF XY:
AC XY:
29
AN XY:
74476
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
30
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.756C>A (p.D252E) alteration is located in exon 3 (coding exon 3) of the EVX1 gene. This alteration results from a C to A substitution at nucleotide position 756, causing the aspartic acid (D) at amino acid position 252 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Gain of glycosylation at P250 (P = 0.1104);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at